These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22691190)

  • 1. C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Yuan J; Gou SJ; Huang J; Hao J; Chen M; Zhao MH
    Arthritis Res Ther; 2012 Jun; 14(3):R140. PubMed ID: 22691190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation.
    Hao J; Huang YM; Zhao MH; Chen M
    Arthritis Res Ther; 2014 Jul; 16(4):R142. PubMed ID: 25000985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation.
    Hao J; Wang C; Yuan J; Chen M; Zhao MH
    PLoS One; 2013; 8(6):e66305. PubMed ID: 23785491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.
    Gou SJ; Yuan J; Wang C; Zhao MH; Chen M
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate and its receptors in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Sun XJ; Wang C; Zhang LX; Yu F; Chen M; Zhao MH
    Nephrol Dial Transplant; 2017 Aug; 32(8):1313-1322. PubMed ID: 28206609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
    Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy.
    Trivioli G; Vaglio A
    Clin Exp Immunol; 2020 Dec; 202(3):403-406. PubMed ID: 32946609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression and clinical significance of neutrophil myeloperoxidase in patients with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Liu Y; Peng XC; Xu JN; Zheng MJ; Shuai ZW
    Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1016-1022. PubMed ID: 36008294
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology.
    Fonseca MI; McGuire SO; Counts SE; Tenner AJ
    J Neuroinflammation; 2013 Feb; 10():25. PubMed ID: 23394121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
    Ohlsson S; Holm L; Hansson C; Ohlsson SM; Gunnarsson L; Pettersson Å; Skattum L
    PLoS One; 2019; 14(6):e0218272. PubMed ID: 31216309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Cheng L; Gou SJ; Qiu HY; Ma L; Fu P
    Clin Exp Immunol; 2018 Jan; 191(1):116-124. PubMed ID: 28940198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How the Availability of Anti-C5a Agents Could Change the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Roccatello D; Fenoglio R; Oddone V; Sciascia S
    Kidney Blood Press Res; 2022; 47(8):506-513. PubMed ID: 35665698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement system activation in ANCA vasculitis: A translational success story?
    Kallenberg CG; Heeringa P
    Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
    Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
    Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis.
    Chen SF; Wang FM; Li ZY; Yu F; Zhao MH; Chen M
    Arthritis Res Ther; 2015 May; 17(1):129. PubMed ID: 25994214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps.
    Huang YM; Wang H; Wang C; Chen M; Zhao MH
    Arthritis Rheumatol; 2015 Oct; 67(10):2780-90. PubMed ID: 26097236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
    Klapa S; Müller A; Koch A; Kerstein-Stähle A; Kähler W; Heidecke H; Schinke S; Huber-Lang M; Nitschke M; Pitann S; Augustin S; Karsten CM; Riemekasten G; Lamprecht P
    Arthritis Rheumatol; 2023 May; 75(5):760-767. PubMed ID: 36409567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5a receptor (CD88) blockade protects against MPO-ANCA GN.
    Xiao H; Dairaghi DJ; Powers JP; Ertl LS; Baumgart T; Wang Y; Seitz LC; Penfold ME; Gan L; Hu P; Lu B; Gerard NP; Gerard C; Schall TJ; Jaen JC; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2014 Feb; 25(2):225-31. PubMed ID: 24179165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.
    Otto M; Hawlisch H; Monk PN; Müller M; Klos A; Karp CL; Köhl J
    J Biol Chem; 2004 Jan; 279(1):142-51. PubMed ID: 14570896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement in ANCA-associated vasculitis.
    Charles Jennette J; Xiao H; Hu P
    Semin Nephrol; 2013 Nov; 33(6):557-64. PubMed ID: 24161040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.